Partners

The consortium consists of a transnational cross-sector partnership, involving six hospitals within fracture management, three companies from the medical technology industry, a research institution as well as three clusters and one technology transfer organisation. This consortium allows to successfully realise the ambitious objectives of the project.

Life Science Nord Management GmbH, Germany

Life Science Nord (LSN) strengthens the value chain in the region and has established itself as one of the leading life science networks in Europe. In over 500 biotech, pharma and medical technology companies and numerous research institutes, 20,000 highly qualified professionals develop innovative medicines, medical products and services in Hamburg and Schleswig-Holstein.

Role in BFCC:

As lead partner Life Science Nord ensures the demand-orientation of the BFCC by matching the varying expectations of hospitals, companies and public stakeholders along the innovation cycle. Moreover, LSN is developing a sustainability strategy for the project.

Contact

Imke Schneemann

Imke Schneemann
Legienstraße 40, 24103 Kiel, Germany
Phone: +49 431 9089 6858
e-mail: schneemann@lifesciencenord.de

www.lifesciencenord.de/en

Stryker Trauma GmbH, Germany

At its German location in Schönkirchen near Kiel, the Stryker Trauma GmbH is specialised in the development and production of intramedullary nails. As such, the Stryker Trauma GmbH is the world leader in intramedullary nailing with an annual production of 400,000 nails. Statistically, every 90 seconds a nail from Schönkirchen is implanted worldwide.

Role in BFCC:

Running the demonstration pilot “infections”.

Contact

Nils Reimers

Nils Reimers
Prof.-Küntscher-Str. 1-5,
24232 Schönkirchen, Germany
e-mail: nils.reimers@stryker.com
www.stryker.de/en

University Medical Center Schleswig-Holstein, Germany

With locations in Kiel and Lübeck, University Medical Center Schleswig-Holstein (UKSH) is one of Europe’s largest medical centres and covers the entire spectrum of modern medicine and health care. The only maximum care provider in Schleswig-Holstein comprises more than 80 clinics and institutions with 2,000 physicians, scientists, researchers, and health staff of 4,000 people.

Role in BFCC:

Implementation and running of one local fracture registry that will supply the transnational registry with data, running the demonstration pilot “complications”, identifying clinical needs.

Contact

Arndt Peter Schulz

Arndt Peter Schulz
Ratzeburger Allee 160, 23538 Lübeck, Germany
e-mail: arndt-peter.schulz@uksh.de

University Medicine Greifswald, Institute for Community Medicine Section Epidemiology of Health Care and Community Health, Germany

The Institute for Community Medicine at the University Medicine Greifswald aims to improve the quality of life of the regional population and to secure high-standard health care. The Section Epidemiology of Health Care and Community Health (ICM-VC) focuses primarily on clinical and population-based projects in health care and epidemiology. The section has a wide experience in data management of epidemiological research. Projects like the German National Cohort demonstrate highest standards in managing high-quality research data and ensuring compliance to legal regulations of data protection. Additionally, within the DFG-Project MOSAIC (Grant number:  HO 1937/2-1) the ICM-VC provides practical templates and tools to address typical aspects of data managements (www.mosaic-greifswald.de).

Role in BFCC:

Implementation of the Transnational IT Infrastructure and Fracture Registries.

Contact

Wolfgang Hoffmann
Director of section Epidemiology of Health Care and Community Health
at the Institute for Community Medicine
Ellernholzstr. 1-2, 17487 Greifswald, Germany

Henriette Rau

Henriette Rau
Institute for Community Medicine
Ellernholzstr. 1-2, 17487 Greifswald, Germany
e-mail: henriette.rau@uni-greifswald.de
www.medizin.uni-greifswald.de

Sahlgrenska University Hospital, Sweden

Sahlgrenska University Hospital provides emergency and basic care for the Göteborg region and its 700,000 inhabitants and highly specialised care for West Sweden with 1.7 million inhabitants.

Role in BFCC:

Running of one local fracture registry that will supply the transnational registry with data, running the demonstration pilot “diagnostics”, identifying clinical needs and carrying out qualification and training events.

Contact

Anders Jönsson

Anders Jönsson
Göteborgsvägen 31, 43180 Mölndal, Sweden
Phone: +46 313 421 000
e-mail: anders.k.jonsson@vgregion.se
www.sahlgrenska.se/en

ScanBalt fmba, Denmark

ScanBalt is the main platform for promoting innovation, competence development and efficient sharing of existing resources and infrastructures in Health and Life Science within the Baltic Sea Region.

Role in BFCC:

Establishment of a transnational network, professional organisation of the dialogue with stakeholders and the marketing of the BFCC R&I infrastructure and services to the BSR companies.

Contact

Peter Frank

Peter Frank
ScanBalt c/o Peter Frank
Allegade 14, 4tv, 2000 Frederiksberg, Denmark
e-mail: pf@scanbalt.org
www.scanbalt.org

Lithuanian University of Health Sciences, Lithuania

The Lithuanian University of Health Sciences is the largest institution of higher education for biomedical sciences in Lithuania, successfully integrating studies, research and clinical practice. More than 1,200 highly qualified doctors and 2,400 members of the nursing staff take care of over 78,000 patients at the LSMU Hospital each year.

Role in BFCC:

Implementation and running of one local fracture registry that will supply the transnational registry with data, running the demonstration pilot “infections”, identifying clinical needs.

Contact

Šarūnas Tarasevičius

Šarūnas Tarasevičius
A. Mickeviciaus g. 9, 44307 Kaunas, Lithuania
e-mail: sarunas.tarasevicius@lsmuni.lt
www.lsmuni.lt/en

LifeScience Krakow Klaster, Poland

LifeScience Klaster Krakow is the network of institutions from Krakow and Małopolska Region to develop and deliver market innovations in the field of life sciences.
These organisations represent six areas of interests: biotechnology and life science business, research & development, science and education, healthcare, business support and local government actively guiding and facilitating the cooperation at the regional level.

Role in BFCC:

Establishment of a transnational network, professional organisation of the dialogue with stakeholders, the marketing of the BFCC R&I infrastructure and services to the BSR companies.

Contact

Kazimierz Murzyn

Kazimierz Murzyn
Bobrzyńskiego 14, 30-348 Kraków, Poland
e-mail: kmurzyn@lifescience.pl
www.lifescience.pl/en

University Hospital in Krakow, Poland

University Hospital in Krakow, one of the biggest in Poland, offers highly specialized medical care for out-patients and in-patients in the framework of different specialties represented by various clinical departments, institutes and out-patient clinics.
At present the University Hospital has 31 departments with almost 1,600 hospital beds, 11 diagnostic institutes and 77 out-patient clinics. University Hospital in Krakow has 3900 highly qualified employees and yearly admits almost 78,000 patients from all over Poland. The number of medical consultations given in out-patient clinics exceeds 496,000 yearly. Hospital is not only providing therapy for patients but also training future medical personnel.

Role in BFCC:

Implementation and running of one local fracture registry that will supply the transnational registry with data, running the demonstration pilot “infections”, identifying clinical needs.

Contact

Grzegorz Szklarczyk

Krzysztof Mydel
UL. Kopernika 36, 31-501 Krakow, Poland
e-mail: kmydel@su.krakow.pl
www.en.su.krakow.pl

University of Tartu, Estonia

The University of Tartu is Estonia's leading centre of research and training. It belongs to the top three per cent of world's best universities. The large research potential of the University of Tartu is evidenced by the fact that it has been invited to join the Coimbra Group, a prestigious club of renowned research universities.

Role in BFCC:

Implementation and running of one local fracture that will supply the transnational registry with data, running the demonstration pilot “complications”, identifying clinical needs.

Contact

Rene Kärner

Rene Kärner
Ravila 19, 50412 Tartu, Estonia
e-mail: rene.karner@ut.ee
www.ut.ee/en

Tartu Biotechnology Park Ltd., Estonia

Tartu Biotechnology Park provides physical infrastructure as well as business development and consultancy services to companies and R&D institutions in the fields of biotechnology, medicine and veterinary medicine. From September 2005 Tartu Biotechnology Park runs the BioMed Incubator for biotechnology, medical and veterinary businesses. The incubator aims to support the formation and sustainable development of enterprises with grow potential.

Role in BFCC:

Establishment of a transnational network, professional organisation of the dialogue with stakeholders, the marketing of the BFCC R&I infrastructure and services to the BSR companies.

Contact

Piia Vettik-Leemet

Piia Vettik-Leemet
Tiigi 61b, 50410 Tartu, Estonia
e-mail: piia@biopark.ee
www.biopark.ee

Andrus Tasa

Andrus Tasa
Tiigi 61b, 50410 Tartu, Estonia
e-mail: atasa@ebc.ee

Bone Index Finland Ltd., Finland

Bone Index is one of the most promising Life Science Company in Scandinavia 2014 (Nordic Star Award) and one of Europe's top new manufacturers of medical devices 2015 (Healthtech Summit). The mission is to reduce the number of osteoporotic fractures by one million globally per year and thus increase the quality of life of families. The aim is bring the diagnostics from special healthcare to primary healthcare with Bindex® point-of-care technology.

Role in BFCC:

Running the demonstration pilot “diagnostics”.

Contact

Ossi Riekkinen

Ossi Riekkinen
Microkatu 1, 70210 Kuopio, Finland
e-mail: ossi.riekkinen@boneindex.fi
www.bindex.fi/en

Janne Karjalainen

Janne Karjalainen
Microkatu 1, 70210 Kuopio, Finland
e-mail: janne.karjalainen@boneindex.fi

BONESUPPORT AB, Sweden

BONESUPPORT™ is a Scandinavian medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures i.e. disease, benign tumors, fracture malunion, augmentation of fracture repair.

Role in BFCC:

Supporting the demonstration pilots ‘infections’ and ‘complications’ from the industrial perspective.

Contact

Eva Lidén

Eva Lidén
Scheelevägen 19, Ideon Science Park,
223 70 Lund, Sweden
e-mail: eva.liden@bonesupport.com
www.bonesupport.com